RNF20 and cancer: A subsequent study expanded this initial proof-of-principle to include five additional genes, which are frequently mutated in cancer (CDC4, MRE11A, RNF20, SMC1A, and SMC3) that are also selectively killed following FEN1 inhibition [53].